ContractClinical Study Agreement • January 26th, 2021
Contract Type FiledJanuary 26th, 2021CLINICAL STUDY AGREEMENT N. 017/OVZ/20/036-P SMLOUVA O PROVÁDĚNÍ KLINICKÉHO HODNOCENÍČ. 017/OVZ/20/036-P THIS CLINICAL STUDY AGREEMENT (this “Agreement”) is effective as of the date of signature of the last Party hereto and effective as of the date of publication in contract registry (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation having a place of business at 830 Winter Street, Waltham, MA 02451, VAT number: 04-2726691 (“ImmunoGen”); Fakultní nemocnice Ostrava, with a place of business at 17. listopadu 1790, 708 52 Ostrava, Czech Republic, ID Number: 00843989, VAT ID Number: CZ00843989, Deed of Foundation of the Ministry of Health of 25th November 1990 File No. OP- 054-25.11.90 in matters of this Agreement is authorized to act and sign: doc. et doc. MUDr. Petr Vávra, Ph.D., Deputy Director for Science, Research and education institution (the “Institution”), and doc. MUDr. Jaroslav Klát, Ph.D., with place of performance at Department of Gyneco